Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system

This publication has 53 references indexed in Scilit:

• Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials
  Multiple Sclerosis Journal, 2000
• Myasthenia Gravis
  New England Journal of Medicine, 1994
• The immunomodulator LS-2616 (linomide) more effectively than sensitization of the donor enhances graft-versus-host reaction after small bowel transplantation
  Transplant Immunology, 1994
• The effect of immunomodulating treatment on cutaneous delayed‐type hypersensitivity in MRL lpr/lpr mice
  APMIS, 1989
• Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice
  Inflammation Research, 1989
• Decreased levels of pathogenic IgG anti-DNA antibodies in autoimmune mice after linomide treatment
  Research in Immunology, 1989
• Mechanism of action of the new immunomodulator LS2616 on T cell responses
  International Journal of Immunopharmacology, 1987
• Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.
  The Journal of Experimental Medicine, 1985
• Antigen-specific interaction between T and B cells
  Nature, 1985
• γ-Interferon is one of several direct B cell-maturing lymphokines
  Nature, 1984